Close

DTYMK

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

DTYMK (Deoxythymidylate Kinase) is a protein coding gene. Among its related pathways are Pyrimidine metabolism (KEGG) and Metabolism. It has proved that the protein has kinase activity and thymidylate kinase activity.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YC0672 Anti-DTYMK (1C4) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1C4 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0673 Anti-DTYMK (1D2) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1D2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0674 Anti-DTYMK (1E12) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1E12 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0675 Anti-DTYMK (1E6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1E6 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0676 Anti-DTYMK (1G8) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1G8 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0677 Anti-DTYMK (1H4) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 1H4 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0678 Anti-DTYMK (2B1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 2B1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0679 Anti-DTYMK (2C2) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 2C2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0680 Anti-DTYMK (2D1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 2D1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0681 Anti-DTYMK (2G11) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 2G11 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0682 Anti-DTYMK (CBYCD-439) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human CBYCD-439 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1572 Anti-DTYMK (1C4) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1C4 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1573 Anti-DTYMK (1D2) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1D2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1574 Anti-DTYMK (1E12) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1E12 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1575 Anti-DTYMK (1E6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1E6 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1576 Anti-DTYMK (1G8) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1G8 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1577 Anti-DTYMK (1H4) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 1H4 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1578 Anti-DTYMK (2B1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 2B1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1579 Anti-DTYMK (2C2) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 2C2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1580 Anti-DTYMK (2D1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 2D1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.